9-137192572-TTCCTCCTCCTCCTCCTCC-TTCCTCCTCCTCC
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP6_Very_StrongBS1
The NM_001128228.3(TPRN):c.1839_1844delGGAGGA(p.Glu614_Glu615del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000663 in 1,608,372 control chromosomes in the GnomAD database, including 2 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0017 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00056 ( 1 hom. )
Consequence
TPRN
NM_001128228.3 disruptive_inframe_deletion
NM_001128228.3 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.06
Genes affected
TPRN (HGNC:26894): (taperin) This locus encodes a sensory epithelial protein. It was defined by linkage analysis in three Pakistani families to lie between D9S1818 (centromeric) and D9SH6 (telomeric). Mutations at this locus have been associated with autosomal recessive deafness. [provided by RefSeq, Oct 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP6
Variant 9-137192572-TTCCTCC-T is Benign according to our data. Variant chr9-137192572-TTCCTCC-T is described in ClinVar as [Benign]. Clinvar id is 179337.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.00165 (250/151268) while in subpopulation EAS AF= 0.0101 (51/5068). AF 95% confidence interval is 0.00786. There are 1 homozygotes in gnomad4. There are 132 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TPRN | NM_001128228.3 | c.1839_1844delGGAGGA | p.Glu614_Glu615del | disruptive_inframe_deletion | 2/4 | ENST00000409012.6 | NP_001121700.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TPRN | ENST00000409012.6 | c.1839_1844delGGAGGA | p.Glu614_Glu615del | disruptive_inframe_deletion | 2/4 | 1 | NM_001128228.3 | ENSP00000387100.4 | ||
TPRN | ENST00000477345.1 | n.2560_2565delGGAGGA | non_coding_transcript_exon_variant | 1/3 | 1 | |||||
TPRN | ENST00000333046.8 | c.1233_1238delGGAGGA | p.Glu412_Glu413del | disruptive_inframe_deletion | 2/3 | 2 | ENSP00000327617.4 |
Frequencies
GnomAD3 genomes AF: 0.00165 AC: 250AN: 151156Hom.: 1 Cov.: 33
GnomAD3 genomes
AF:
AC:
250
AN:
151156
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00188 AC: 395AN: 209928Hom.: 0 AF XY: 0.00165 AC XY: 188AN XY: 113872
GnomAD3 exomes
AF:
AC:
395
AN:
209928
Hom.:
AF XY:
AC XY:
188
AN XY:
113872
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000561 AC: 817AN: 1457104Hom.: 1 AF XY: 0.000534 AC XY: 387AN XY: 724688
GnomAD4 exome
AF:
AC:
817
AN:
1457104
Hom.:
AF XY:
AC XY:
387
AN XY:
724688
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00165 AC: 250AN: 151268Hom.: 1 Cov.: 33 AF XY: 0.00179 AC XY: 132AN XY: 73908
GnomAD4 genome
AF:
AC:
250
AN:
151268
Hom.:
Cov.:
33
AF XY:
AC XY:
132
AN XY:
73908
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 06, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 02, 2019 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 05, 2013 | Glu620_Glu621del in Exon 2 of TPRN: This variant is not expected to have clinica l significance because it has been identified in 1.5% (114/7666) of European Ame rican chromosomes and 1.2% (46/3904) of African American chromosomes by the NHLB I Exome sequencing project (http://evs.gs.washington.edu/EVS/; dbSNP rs77086130) . - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at